Newron Pharmaceuticals To Present 2015 Financial Results On March 1, 2016
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today announces the company will present its 2015 full-year financial results in Zurich at 9:15 a.m. CET, 3:15 a.m. ET on Tuesday, March 1, 2016.